↓ Skip to main content

Efficacy and Safety of Vadadustat for Anemia in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Overview of attention for article published in Frontiers in Pharmacology, January 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and Safety of Vadadustat for Anemia in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Published in
Frontiers in Pharmacology, January 2022
DOI 10.3389/fphar.2021.795214
Pubmed ID
Authors

Limei Xiong, Hui Zhang, Yannan Guo, Yue Song, Yuhong Tao

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer 3 13%
Professor > Associate Professor 3 13%
Student > Master 2 8%
Student > Ph. D. Student 1 4%
Unspecified 1 4%
Other 2 8%
Unknown 12 50%
Readers by discipline Count As %
Medicine and Dentistry 5 21%
Nursing and Health Professions 4 17%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Chemistry 1 4%
Unspecified 1 4%
Other 0 0%
Unknown 11 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2022.
All research outputs
#18,195,618
of 23,371,053 outputs
Outputs from Frontiers in Pharmacology
#7,450
of 16,848 outputs
Outputs of similar age
#344,798
of 506,463 outputs
Outputs of similar age from Frontiers in Pharmacology
#472
of 1,178 outputs
Altmetric has tracked 23,371,053 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,848 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 506,463 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,178 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.